SAPIOTEC GMBH has a total of 80 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, macromolecular chemistry and polymers and micro-structure and nano-technology are YANG DAVID J, SERENE LLC and DEXTECH MEDICAL AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 16 | |
#2 | WIPO (World Intellectual Property Organization) | 14 | |
#3 | United States | 12 | |
#4 | China | 11 | |
#5 | Canada | 10 | |
#6 | Republic of Korea | 10 | |
#7 | Hong Kong | 5 | |
#8 | Japan | 1 | |
#9 | Serbia | 1 |
# | Name | Total Patents |
---|---|---|
#1 | Roewer Norbert | 78 |
#2 | Broscheit Jens | 78 |
#3 | Steer Isabell | 2 |
#4 | Jens Broscheit | 1 |
#5 | Roewer Norbert Prof Dr | 1 |
#6 | Norbert Roewer | 1 |
#7 | Broscheit Jens Dr Med | 1 |
Publication | Filing date | Title |
---|---|---|
CN112040984A | Pharmaceutical formulation, method for preparing a pharmaceutical formulation and medicament comprising the same | |
EP3360539A1 | Pharmaceutical formulation | |
EP3009126A1 | Oromucosal film preparation | |
EP2913366A1 | Anthocyanidin complex | |
EP2913050A1 | Method for producing a flurane complex | |
EP2907518A1 | Analgesic | |
CN104936601A | Delphinidin for combating melanoma cells | |
CN104870001A | Delphinidin complex as an antiphlogistic or immunosuppressive active ingredient | |
KR20150070303A | Anthocyanidin complex for the treatment of multiple myeloma | |
WO2013144306A1 | Use of delphinidin against staphylococcus aureus | |
CA2869056A1 | Anthocyanidin complex | |
EP2345427A1 | Fluoran complex |